


Aagenaes Syndrome, also known as Cholestasis-Lymphedema Syndrome, is a rare inherited disorder that primarily affects the liver and lymphatic system. Here’s a comprehensive overview:
Overview
-
Name: Aagenaes Syndrome (also called Lymphedema-Cholestasis Syndrome 1)
-
Inheritance: Autosomal recessive
-
First described: By Øystein Aagenaes, a Norwegian pediatrician, in 1968
-
OMIM Number: #214900
Key Features
-
Neonatal Cholestasis:
-
Begins in infancy
-
Caused by impaired bile flow from the liver
-
Leads to jaundice, itching, and fat malabsorption
-
Often improves spontaneously in early childhood but can recur or become chronic
-
-
Lymphedema:
-
Usually appears in early childhood or later
-
Most commonly affects lower limbs
-
Can be mild to severe
-
May worsen with age
-
-
Liver Disease Progression:
-
Some patients develop fibrosis, cirrhosis, or even liver failure
-
Variable severity
-
-
Other Possible Symptoms:
-
Vitamin deficiencies (especially A, D, E, K) due to fat malabsorption
-
Growth delay
-
Muscle weakness in severe cases
-
Causes and Genetics
-
Caused by mutations in the CCBE1 gene (Collagen and Calcium Binding EGF Domains 1)
-
The gene plays a role in lymphangiogenesis (formation of lymphatic vessels)
-
The exact mechanism linking the gene mutation to liver cholestasis is not fully understood
Diagnosis
-
Clinical presentation of cholestasis in infancy + lymphedema later
-
Liver function tests (elevated bilirubin, bile acids, GGT)
-
Liver biopsy may show intrahepatic cholestasis and fibrosis
-
Genetic testing to confirm mutations in CCBE1
-
Lymphoscintigraphy or other imaging to assess lymphatic system
Treatment and Management
There is no cure, so treatment focuses on managing symptoms:
-
Cholestasis Management:
-
Ursodeoxycholic acid (to improve bile flow)
-
Fat-soluble vitamin supplementation
-
Nutritional support
-
-
Lymphedema Care:
-
Compression garments
-
Physical therapy
-
Manual lymph drainage
-
-
Liver Monitoring:
-
Regular follow-up
-
Liver transplantation may be needed in severe liver failure
-
-
Genetic Counseling:
-
Essential for affected families
-
Carrier testing and prenatal diagnosis are options
-
Epidemiology
-
Very rare: Around 100 reported cases, mostly from Scandinavia, particularly Norway
-
Higher incidence in certain isolated populations due to founder mutations
Prognosis
-
Highly variable
-
Some individuals have mild symptoms and live normal lives
-
Others may develop severe liver disease or disabling lymphedema